BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 24684760)

  • 1. Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives.
    Kitabata H; Waksman R; Warnack B
    Cardiovasc Revasc Med; 2014 Mar; 15(2):109-16. PubMed ID: 24684760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem.
    Foin N; Lee R; Wong P; Low AF
    EuroIntervention; 2015 Aug; 11(4):e1. PubMed ID: 26298237
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of bioresorbable scaffolds: hype or hope?
    Tan HC; Ananthakrishna R
    Singapore Med J; 2017 Sep; 58(9):512-515. PubMed ID: 27868135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioresorbable Stents: Is This Where We Are Headed?
    Wayangankar SA; Ellis SG
    Prog Cardiovasc Dis; 2015; 58(3):342-55. PubMed ID: 26319497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel drug-eluting stents for coronary revascularization.
    Gogas BD; McDaniel M; Samady H; King SB
    Trends Cardiovasc Med; 2014 Oct; 24(7):305-13. PubMed ID: 25240980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioresorbable vascular scaffold implantation for recurrent in-stent restenosis: an option in case of multiple failures?
    Ielasi A; Saino A; Silvestro A; Personeni D; Tespili M
    EuroIntervention; 2014 Jul; 10(3):337. PubMed ID: 24647134
    [No Abstract]   [Full Text] [Related]  

  • 8. [The bioresorbable coronary scaffold].
    Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
    Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.
    Ielasi A; Tespili M
    Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioresorbable Scaffold: The Emerging Reality and Future Directions.
    Sotomi Y; Onuma Y; Collet C; Tenekecioglu E; Virmani R; Kleiman NS; Serruys PW
    Circ Res; 2017 Apr; 120(8):1341-1352. PubMed ID: 28408454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of bioresorbable scaffolds in the treatment of coronary artery disease.
    Wiebe J; Nef HM; Hamm CW
    J Am Coll Cardiol; 2014 Dec; 64(23):2541-51. PubMed ID: 25500240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 13. From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.
    Tenekecioglu E; Bourantas C; Abdelghani M; Zeng Y; Silva RC; Tateishi H; Sotomi Y; Onuma Y; Yılmaz M; Serruys PW
    Expert Rev Med Devices; 2016; 13(3):271-86. PubMed ID: 26782080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking into the future with bioresorbable vascular scaffolds.
    Costopoulos C; Naganuma T; Latib A; Colombo A
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1407-16. PubMed ID: 24138526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioresorbable scaffolds for the SFA: new developments.
    Werner M
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):455-9. PubMed ID: 24866776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable.
    Wiebe J; Hamm C; Nef H
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1184-8. PubMed ID: 25581885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioresorbable Vascular Scaffold: A Focused Review on Development and Preclinical Studies].
    Ke L; Huang Y; Liu L; Duan X; Feng X; Wang C
    Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Feb; 42(2):115-118. PubMed ID: 29845812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial 2-dimensional and 3-dimensional optical coherence tomography assessment of overhanging struts of drug-eluting absorbable metal scaffold: "DREAMS" for jailed side branch?
    Muramatsu T; García-García HM; Serruys PW; Waksman R; Verheye S;
    JACC Cardiovasc Interv; 2014 May; 7(5):575-6. PubMed ID: 24852807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.